2017
DOI: 10.1016/j.eurpolymj.2017.08.032
|View full text |Cite
|
Sign up to set email alerts
|

Controlled-release solid dispersions of Eudragit® FS 100 and poorly soluble spironolactone prepared by electrospinning and melt extrusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
26
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1
1

Relationship

2
6

Authors

Journals

citations
Cited by 42 publications
(26 citation statements)
references
References 37 publications
0
26
0
Order By: Relevance
“…In addition to the conventional use as granules, powders, and aqueous solutions, Eudragit copolymers have been applied as support for electrospinning procedure . The retention in the bioactivity of specific molecules—proteins and drugs (such as spironolactone, budesonide, and indomethacin) in aggressive acidic environments (stomach) and release throughout ileum and colon represent important applications for Eudragit‐based electrospun fibers …”
Section: Introductionmentioning
confidence: 99%
“…In addition to the conventional use as granules, powders, and aqueous solutions, Eudragit copolymers have been applied as support for electrospinning procedure . The retention in the bioactivity of specific molecules—proteins and drugs (such as spironolactone, budesonide, and indomethacin) in aggressive acidic environments (stomach) and release throughout ileum and colon represent important applications for Eudragit‐based electrospun fibers …”
Section: Introductionmentioning
confidence: 99%
“…However, the productivity of SNES does not satisfy the pharmaceutical requirements thus scaling-up of the technology is essential. In recent years, many methods have been created for this purpose such as needleless electrospinning [25][26][27][28], multineedle electrospinning [29], alternating current electrospinning [30][31][32], and high-speed electrospinning (HSES) [33]. The latter one, where electrostatic and centrifugal forces are combined, may be a highly suitable technology in the pharmaceutical industry for mass production of fibrous drug delivery systems.…”
mentioning
confidence: 99%
“…Among the different kinds of strategies that have been broadly investigated to resolve this problem, drug solid dispersions (SDs) are some of the most promising ways with many commercial products [ 5 , 6 , 7 , 8 , 9 ]. New methods for creating new kinds of high-performance SDs are always desired and are thus becoming a rapidly developing branch of pharmaceutical technologies [ 10 , 11 , 12 , 13 , 14 , 15 ].…”
Section: Introductionmentioning
confidence: 99%